In vivo and in vitro potency studies of 6β-naltrexol, the major human metabolite of naltrexone

Addiction Biology

Volumn 7, Issue 2, 2002, Pages 219-225

  Porter, Susan J ^a   Somogyi, Andrew A ^a   White, Jason M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MORPHINE; NALOXONE; NALTREXOL; NALTREXONE; OPIATE;

ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; ELECTROSTIMULATION; GUINEA PIG; HOT PLATE TEST; ILEUM; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTROINTESTINAL MOTILITY; GUINEA PIGS; ILEUM; ISOMETRIC CONTRACTION; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN THRESHOLD; RECEPTORS, OPIOID, MU;

EID: 0036255855     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/135562102200120442     Document Type: Article

References (21)

1. Naltrexone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence
2. Pharmacotherapy of alcoholism - 10 Years of progress
3. Isolation and stereochemical identification of a metabolite of naltrexone from human urine
4. Metabolism and disposition of naltrexone in man after oral and intravenous administration
5. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration
6. Effect of liver cirrhosis on the systemic availability of naltrexone in humans
7. Naltrexone disposition in man after subcutaneous administration
8. 6-β-Naltrexol reduces alcohol consumption in rats
9. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers
10. The urinary excretion profile of naltrexone and metabolites in man
11. Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing
12. Active drug metabolites - An overview of their relevance in clinical pharmacokinetics
13. Naltrexone biotransformation and incidence of subjective side effects: A preliminary study
14. Stereospecific synthesis of the 6β-hydroxy metabolites of naltrexone and naloxone
15. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine-dependent mice
16. Comparison of naltrexone and 6β-naltrexol for narcotic antagonist activity in rats and mice
17. Comparative antagonism by naltrexone and naloxone of μ, κ and δ agonists
18. Naltrexone, naloxone and related noroxymorphones
19. Preclinical study of an oral controlled release naltrexone complex in mice
20. Determination of naltrexone and 6-beta naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry
21. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, α-naltrexol, or β-naltrexol